×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MIRA – mira pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MIRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
08:02 am
mira
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site [Yahoo! Finance]
High
Report
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site [Yahoo! Finance]
11/20
07:44 am
mira
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
High
Report
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
10/28
07:30 am
mira
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain
Medium
Report
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain
10/21
07:30 am
mira
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
High
Report
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
10/2
05:59 am
mira
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Low
Report
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
9/30
01:04 pm
mira
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
Medium
Report
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
9/27
07:30 am
mira
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024
Medium
Report
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024
9/18
07:00 am
mira
MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025
High
Report
MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/19
05:58 pm
mira
Form 144 MIRA PHARMACEUTICALS, Filed by: Aminov Erez
Medium
Report
Form 144 MIRA PHARMACEUTICALS, Filed by: Aminov Erez
11/19
04:10 pm
mira
Form 8-K MIRA PHARMACEUTICALS, For: Nov 19
Medium
Report
Form 8-K MIRA PHARMACEUTICALS, For: Nov 19
11/12
04:06 pm
mira
Form 10-Q MIRA PHARMACEUTICALS, For: Sep 30
Low
Report
Form 10-Q MIRA PHARMACEUTICALS, For: Sep 30
10/25
04:01 pm
mira
Form 8-K MIRA PHARMACEUTICALS, For: Oct 25
High
Report
Form 8-K MIRA PHARMACEUTICALS, For: Oct 25
10/21
07:00 am
mira
Form 8-K MIRA PHARMACEUTICALS, For: Oct 21
Medium
Report
Form 8-K MIRA PHARMACEUTICALS, For: Oct 21
9/27
05:21 pm
mira
Form 424B5 MIRA PHARMACEUTICALS,
High
Report
Form 424B5 MIRA PHARMACEUTICALS,
9/12
04:31 pm
mira
Form 8-K MIRA PHARMACEUTICALS, For: Sep 12
Low
Report
Form 8-K MIRA PHARMACEUTICALS, For: Sep 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: